Advertisement
Singapore markets close in 1 hour 24 minutes
  • Straits Times Index

    3,286.51
    -6.62 (-0.20%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,279.45
    +78.18 (+0.45%)
     
  • FTSE 100

    8,078.29
    +37.91 (+0.47%)
     
  • Bitcoin USD

    64,230.76
    -2,570.49 (-3.85%)
     
  • CMC Crypto 200

    1,391.03
    +8.46 (+0.61%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,334.60
    -3.80 (-0.16%)
     
  • Crude Oil

    82.99
    +0.18 (+0.22%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.04
    -1.44 (-0.09%)
     
  • Jakarta Composite Index

    7,155.00
    -19.53 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

What Analysts Think of Endo International

What Analysts Think of Endo International

Of the 19 analysts covering Endo International (ENDP) stock in July, four of them have given the stock a “buy” or higher rating, 14 have given it a “hold,” and one has given it a “sell.” The mean rating for the stock is 2.74 with a target price of $8.53. Sixteen of the 20 analysts covering Abbott Laboratories (ABT) in July have given the stock a “buy” or higher rating, and four have given it a “hold.” The mean rating for the stock is 1.8 with a target price of $69.